Miriplatin
Miriplatin (SM-11355) is a derivative of cisplatin containing myristates as a carrier ligand. It is a novel lipophilic platinum complex developed to treat hepatocellular carcinoma.DMSO is not recommended to dissolve platinum-based drugs, which can easily lead to drug inactivation.
| Trivial name | SM-11355 |
| Catalog Number | S5024 |
| Molecular Formula | C34H68N2O4Pt |
| CAS# | 141977-79-9 |
| Inchi | InChI=1S/2C14H28O2.C6H14N2.Pt/c2*1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16;7-5-3-1-2-4-6(5)8;/h2*2-13H2,1H3,(H,15,16);5-6H,1-4,7-8H2;/q;;;+2/p-2/t;;5-,6-;/m..1./s1 |
| Inchi Key | BGIHRZPJIYJKAZ-BLUNCNMSSA-L |
| Size | 1g |
| Supplier Page | http://www.selleckchem.com/products/miriplatin.html |
| Additional Information | https://file.selleck.cn/downloads/struct/miriplatin-chemical-structure-s5024.gif |